179 related articles for article (PubMed ID: 35888686)
1. Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy.
Hallali G; Seyed Z; Maillard AV; Drine K; Lamour L; Faure C; Audo I
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888686
[No Abstract] [Full Text] [Related]
2. Pericentral hydroxychloroquine retinopathy in Korean patients.
Lee DH; Melles RB; Joe SG; Lee JY; Kim JG; Lee CK; Yoo B; Koo BS; Kim JT; Marmor MF; Yoon YH
Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
[TBL] [Abstract][Full Text] [Related]
3. Early onset monocular hydroxychloroquine maculopathy in a systemic lupus erythematosus patient with history of central retinal artery occlusion: a case report.
Ameen Ismail A; Sadek SH; Hatata RM
BMC Ophthalmol; 2022 Nov; 22(1):434. PubMed ID: 36376841
[TBL] [Abstract][Full Text] [Related]
4. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.
Melles RB; Marmor MF
Ophthalmology; 2015 Jan; 122(1):110-6. PubMed ID: 25182842
[TBL] [Abstract][Full Text] [Related]
5. A possible early sign of hydroxychloroquine macular toxicity.
Brandao LM; Palmowski-Wolfe AM
Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
[TBL] [Abstract][Full Text] [Related]
6. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome-Lysosomal Pathway and Sphingolipid Metabolism in the Retina.
Mondal K; Porter H; Cole J; Pandya HK; Basu SK; Khanam S; Chiu CY; Shah V; Stephenson DJ; Chalfant CE; Mandal N
Mol Neurobiol; 2022 Jun; 59(6):3873-3887. PubMed ID: 35426574
[TBL] [Abstract][Full Text] [Related]
8. Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography.
Turgut B; Turkcuoglu P; Serdar Koca S; Aydemir O
Clin Rheumatol; 2009 May; 28(5):607-9. PubMed ID: 19221829
[TBL] [Abstract][Full Text] [Related]
9. Macular toxicity after short-term hydroxychloroquine therapy.
Pasaoglu I; Onmez FE
Indian J Ophthalmol; 2019 Feb; 67(2):289-292. PubMed ID: 30672499
[TBL] [Abstract][Full Text] [Related]
10. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
12. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
Vanderzee G; Tassi D
Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
Eo DR; Lee MG; Ham DI; Kang SW; Lee J; Cha HS; Koh E; Kim SJ
J Korean Med Sci; 2017 Mar; 32(3):522-527. PubMed ID: 28145658
[TBL] [Abstract][Full Text] [Related]
14. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity.
Debellemanière G; Flores M; Tumahai P; Meillat M; Bidaut Garnier M; Delbosc B; Saleh M
Acta Ophthalmol; 2015 Nov; 93(7):e534-40. PubMed ID: 25989823
[TBL] [Abstract][Full Text] [Related]
15. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
de Sisternes L; Hu J; Rubin DL; Marmor MF
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
[TBL] [Abstract][Full Text] [Related]
16. Ocular findings in Japanese patients with hydroxychloroquine retinopathy developing within 3 years of treatment.
Ozawa H; Ueno S; Ohno-Tanaka A; Sakai T; Hashiguchi M; Shimizu M; Fujinami K; Ahn SJ; Kondo M; Browning DJ; Shinoda K; Yokogawa N
Jpn J Ophthalmol; 2021 Jul; 65(4):472-481. PubMed ID: 34014447
[TBL] [Abstract][Full Text] [Related]
17. Recessive Stargardt disease phenocopying hydroxychloroquine retinopathy.
Nõupuu K; Lee W; Zernant J; Greenstein VC; Tsang S; Allikmets R
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):865-72. PubMed ID: 26311262
[TBL] [Abstract][Full Text] [Related]
18. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
19. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
Agarwal P; Wong YH; Dasgupta E; Agarwal R; Livingstone BI; Ramamurthy S; Chyn GS
Cutan Ocul Toxicol; 2015; 34(3):179-84. PubMed ID: 25068998
[TBL] [Abstract][Full Text] [Related]
20. Pericentral hydroxychloroquine retinopathy in a Caucasian female.
Anand N; Prinzi RA; Hoeferlin C; Yan J; Jain N
Am J Ophthalmol Case Rep; 2018 Mar; 9():93-95. PubMed ID: 29577098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
